Pediatric metabolic syndrome (MetS) is a well-recognized entity; however, there is no consensus on its exact value in predicting long-term cardiovascular (CV) risk. Hepatic steatosis (HS) is another emerging condition associated with pediatric obesity, and data have been reported suggesting a possible role of HS in CV risk linked to MetS. The aim of the present study was to evaluate the usefulness of HS and MetS cluster in predicting CV risk linked to pediatric obesity.
Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children
RUTIGLIANO, IRENE;VINCI, ROBERTA;MANCINI, MONICA;STOPPINO, LUCA PIO;d'Apolito, Maria;GIARDINO, IDA;MACARINI, LUCA;PETTOELLO MANTOVANI, MASSIMO;CAMPANOZZI, ANGELO SALVATORE
2017-01-01
Abstract
Pediatric metabolic syndrome (MetS) is a well-recognized entity; however, there is no consensus on its exact value in predicting long-term cardiovascular (CV) risk. Hepatic steatosis (HS) is another emerging condition associated with pediatric obesity, and data have been reported suggesting a possible role of HS in CV risk linked to MetS. The aim of the present study was to evaluate the usefulness of HS and MetS cluster in predicting CV risk linked to pediatric obesity.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
